34948275|t|The Nutritional Supplement L-Alpha Glycerylphosphorylcholine Promotes Atherosclerosis.
34948275|a|L-alpha glycerylphosphorylcholine (GPC), a nutritional supplement, has been demonstrated to improve neurological function. However, a new study suggests that GPC supplementation increases incident stroke risk thus its potential adverse effects warrant further investigation. Here we show that GPC promotes atherosclerosis in hyperlipidemic Apoe-/- mice. GPC can be metabolized to trimethylamine N-oxide, a pro-atherogenic agent, suggesting a potential molecular mechanism underlying the observed atherosclerosis progression. GPC supplementation shifted the gut microbial community structure, characterized by increased abundance of Parabacteroides, Ruminococcus, and Bacteroides and decreased abundance of Akkermansia, Lactobacillus, and Roseburia, as determined by 16S rRNA gene sequencing. These data are consistent with a reduction in fecal and cecal short chain fatty acids in GPC-fed mice. Additionally, we found that GPC supplementation led to an increased relative abundance of choline trimethylamine lyase (cutC)-encoding bacteria via qPCR. Interrogation of host inflammatory signaling showed that GPC supplementation increased expression of the proinflammatory effectors CXCL13 and TIMP-1 and activated NF-kappaB and MAPK signaling pathways in human coronary artery endothelial cells. Finally, targeted and untargeted metabolomic analysis of murine plasma revealed additional metabolites associated with GPC supplementation and atherosclerosis. In summary, our results show GPC promotes atherosclerosis through multiple mechanisms and that caution should be applied when using GPC as a nutritional supplement.
34948275	27	60	L-Alpha Glycerylphosphorylcholine	Chemical	MESH:D005997
34948275	70	85	Atherosclerosis	Disease	MESH:D050197
34948275	87	120	L-alpha glycerylphosphorylcholine	Chemical	MESH:D005997
34948275	122	125	GPC	Chemical	MESH:D005997
34948275	245	248	GPC	Chemical	MESH:D005997
34948275	284	290	stroke	Disease	MESH:D020521
34948275	380	383	GPC	Chemical	MESH:D005997
34948275	393	408	atherosclerosis	Disease	MESH:D050197
34948275	435	439	mice	Species	10090
34948275	441	444	GPC	Chemical	MESH:D005997
34948275	467	489	trimethylamine N-oxide	Chemical	MESH:C005855
34948275	497	508	atherogenic	Disease	MESH:D050197
34948275	583	598	atherosclerosis	Disease	MESH:D050197
34948275	612	615	GPC	Chemical	MESH:D005997
34948275	754	765	Bacteroides	Species	816
34948275	793	804	Akkermansia	Species	239934
34948275	806	819	Lactobacillus	Species	1578
34948275	825	834	Roseburia	Species	841
34948275	941	964	short chain fatty acids	Chemical	MESH:D005232
34948275	968	971	GPC	Chemical	MESH:D005997
34948275	976	980	mice	Species	10090
34948275	1010	1013	GPC	Chemical	MESH:D005997
34948275	1102	1106	cutC	Gene	66388
34948275	1158	1170	inflammatory	Disease	MESH:D007249
34948275	1193	1196	GPC	Chemical	MESH:D005997
34948275	1241	1256	proinflammatory	Disease	
34948275	1267	1273	CXCL13	Gene	10563
34948275	1278	1284	TIMP-1	Gene	7076
34948275	1299	1308	NF-kappaB	Gene	4790
34948275	1340	1345	human	Species	9606
34948275	1438	1444	murine	Species	10090
34948275	1500	1503	GPC	Chemical	MESH:D005997
34948275	1524	1539	atherosclerosis	Disease	MESH:D050197
34948275	1570	1573	GPC	Chemical	MESH:D005997
34948275	1583	1598	atherosclerosis	Disease	MESH:D050197
34948275	1673	1676	GPC	Chemical	MESH:D005997
34948275	Positive_Correlation	MESH:D005997	4790
34948275	Positive_Correlation	MESH:D005997	66388
34948275	Positive_Correlation	MESH:D005997	MESH:D050197
34948275	Positive_Correlation	MESH:D005997	MESH:D020521
34948275	Positive_Correlation	MESH:D005997	7076
34948275	Negative_Correlation	MESH:D005232	MESH:D005997
34948275	Positive_Correlation	MESH:C005855	MESH:D050197
34948275	Association	MESH:C005855	MESH:D005997
34948275	Positive_Correlation	MESH:D005997	10563

